Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 100861
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.100861
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.100861
Figure 3 Serum alpha-fetoprotein and antagonist-II dropped to normal levels 4 months after selective internal radiation therapy.
AFP: Alpha-fetoprotein; PIVKA: Antagonist-II.
- Citation: Hao MZ, Lin HL, Hu YB, Chen QZ, Chen ZX, Qiu LB, Lin DY, Zhang H, Zheng DC, Fang ZT, Liu JF. Combination therapy strategy based on selective internal radiation therapy as conversion therapy for inoperable giant hepatocellular carcinoma: A case report. World J Gastrointest Oncol 2025; 17(3): 100861
- URL: https://www.wjgnet.com/1948-5204/full/v17/i3/100861.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i3.100861